Albion Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6K	Buy	520 +400	+333%	+$1.55K	﹤0.01%	590
2025 Q4	$491	Hold	120	–	–	﹤0.01%	608
2025 Q3	$586	Hold	120	–	–	﹤0.01%	605
2025 Q2	$608	Hold	120	–	–	﹤0.01%	539
2025 Q1	$635	Hold	120	–	–	﹤0.01%	555
2024 Q4	$812	Hold	120	–	–	﹤0.01%	622
2024 Q3	$791	Hold	120	–	–	﹤0.01%	464
2024 Q2	$900	Hold	120	–	–	﹤0.01%	464
2024 Q1	$1.2K	Hold	120	–	–	﹤0.01%	443
2023 Q4	$1.18K	Hold	120	–	–	﹤0.01%	419
2023 Q3	$918	Hold	120	–	–	﹤0.01%	425
2023 Q2	$897	Sell	120 -4,063	-97%	-$28.4K	﹤0.01%	421
2023 Q1	$27.9K	Hold	4,183	–	–	﹤0.01%	236
2022 Q4	$32.3K	Buy	4,183 +1	+0%	+$10	﹤0.01%	232
2022 Q3	$44K	Buy	4,182 +4,062	+3,385%	+$41.1K	﹤0.01%	219
2022 Q2	$1K	Hold	120	–	–	﹤0.01%	503
2022 Q1	$1K	Sell	120 -6,094	-98%	-$64.8K	﹤0.01%	569
2021 Q4	$106K	Buy	+6,214	New	+$117K	0.01%	243